- Home
- AREB vs LYRA Comparison
AREB vs LYRA Comparison
Compare AREB & LYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AREB
- LYRA
- Stock Information
- Founded
- AREB 2014
- LYRA 2005
- Country
- AREB United States
- LYRA United States
- Employees
- AREB N/A
- LYRA N/A
- Industry
- AREB Plastic Products
- LYRA Medical/Dental Instruments
- Sector
- AREB Industrials
- LYRA Health Care
- Exchange
- AREB Nasdaq
- LYRA Nasdaq
- Market Cap
- AREB 6.8M
- LYRA 7.6M
- IPO Year
- AREB N/A
- LYRA 2020
- Fundamental
- Price
- AREB $1.05
- LYRA $3.25
- Analyst Decision
- AREB
- LYRA Hold
- Analyst Count
- AREB 0
- LYRA 1
- Target Price
- AREB N/A
- LYRA $16.00
- AVG Volume (30 Days)
- AREB 1.2M
- LYRA 31.4K
- Earning Date
- AREB 11-10-2025
- LYRA 11-12-2025
- Dividend Yield
- AREB N/A
- LYRA N/A
- EPS Growth
- AREB N/A
- LYRA N/A
- EPS
- AREB N/A
- LYRA N/A
- Revenue
- AREB $9,014,691.00
- LYRA $600,000.00
- Revenue This Year
- AREB N/A
- LYRA N/A
- Revenue Next Year
- AREB N/A
- LYRA $106.28
- P/E Ratio
- AREB N/A
- LYRA N/A
- Revenue Growth
- AREB N/A
- LYRA N/A
- 52 Week Low
- AREB $0.91
- LYRA $3.10
- 52 Week High
- AREB $1,835.00
- LYRA $37.50
- Technical
- Relative Strength Index (RSI)
- AREB 41.45
- LYRA 18.37
- Support Level
- AREB $1.05
- LYRA $5.40
- Resistance Level
- AREB $1.14
- LYRA $3.99
- Average True Range (ATR)
- AREB 0.18
- LYRA 0.35
- MACD
- AREB 0.11
- LYRA -0.10
- Stochastic Oscillator
- AREB 19.79
- LYRA 3.34
About AREB American Rebel Holdings Inc.
American Rebel Holdings Inc develops self-defense, safe storage, and patriotic product areas using a wholesale distribution network, utilizing personal appearances, musical venue performances, as well as e-commerce and television. It designs, manufactures, and markets concealed carry products. It offers products ranging in Backpacks, jackets, coats, and Others. The Company views its operations and manages its business as one operating segment engaged in patriotic goods, comprised of safes, soft goods, and beer.
About LYRA Lyra Therapeutics Inc.
Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.